Under the agreement, Bionova will serve as the preferred manufacturing partner for Syenex’s best-in-class delivery platforms.

Bionova Scientific LLC, an Asahi Kasei company and a bespoke contract development and manufacturing organization (CDMO), announced a strategic manufacturing alliance with Syenex, a genetic medicines ...

Brennan Investment Group ("Brennan"), a private real estate investment firm that acquires, develops, and operates industrial ...

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders ...

The study reveals that environmental stressors do not merely kill bacteria; they can also prime surviving cells to take up ...

Year Customer Agreement Represents Largest LineaDNA Order in Company History Company Expects to Ship over $1.5M of LineaDNA in 1HCY2026NEW YORK--(BUSINESS WIRE)--BNB Plus Corp. (Nasdaq: BNBX) (“BNBX” ...

The global cell and gene therapy third-party logistics market size was valued at USD 1.81 billion in 2025 and is predicted to hit around USD 16.95 billion by 2035, rising at a 25.05% CAGR, a study ...

Environmental antimicrobial resistance is turning rivers, soils, and even the air into hidden highways for "superbugs," ...

Evidence from multiple model systems supports a shift away from heme transport and toward metabolic dysfunction and oxidative stress as key drivers of TANGO2 deficiency.

HIV hijacks SRRM2 to enlarge nuclear speckles, stabilizing CPSF6 puncta and promoting efficient viral replication.